Thromboxane A2 Receptor antagonism and antioxidant action of cin

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A01N 6500, A61K 3578

Patent

active

058537317

ABSTRACT:
A pharmaceutical composition which possesses vasorelaxing effect of aortic contraction, relaxing effect of tracheal contraction, and antioxidative properties, is disclosed. It contains a pharmaceutical acceptable vehicle and an effective amount of any compound selected from those compounds represented by the following formula: ##STR1## where R.sub.1 represents H, C.sub.1-8 alkyl, or --OCOR, R.sub.2 represents OH, or COO.sup.--, and R represents H, or C.sub.1-8 alkyl.

REFERENCES:
patent: 4595693 (1986-06-01), Biftu
patent: 4595963 (1986-06-01), Biftu
Han et. al., Chemical Abstracts, vol. 104(23), 1986, #203866a.
Biftu et. al., Chemical Abstracts, vol. 90(7), 1979, #54746z.
Hoffmann-LaRoche, Chemical Abstracts, vol. 76(23), 1972, #140220r.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Thromboxane A2 Receptor antagonism and antioxidant action of cin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Thromboxane A2 Receptor antagonism and antioxidant action of cin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thromboxane A2 Receptor antagonism and antioxidant action of cin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1421627

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.